Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)
Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –
Bioventus pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bioventus's pe ratio was 13.7× on Nov 11, 2026, against 69.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.7× | −53.9 |
| 2025 | Dec 31, 2025 | 67.6× | +39.4 |
| 2022 | Apr 29, 2022 | 28.2× | – |
See a number that looks wrong?